|
2024
|
Invention
|
Plxdc1/plxdc2 activators and their use in the treatment of blood vessel disorders.
Pathogenic bl... |
|
2023
|
Invention
|
Compounds and methods for targeting pathogenic blood vessels. The disclosure provides compounds, ... |
|
2022
|
Invention
|
Activating antibodies of receptor proteins plxdc1 and plxdc2.
PLXDC1 and PLXDC2 represent a new ... |
|
|
Invention
|
Activating antibodies of receptor proteins plxdc1 and plxdc2. PLXDC1 and PLXDC2 represent a new c... |
|
2020
|
Invention
|
Methods and compositions for treating pathogenic blood vessel disorders.
Pathogenic blood vessel... |
|
|
Invention
|
3-phenylsulphonyl-quinoline derivatives as agents for treating pathogenic blood vessels disorders... |
|
|
Invention
|
Plxdc activators and their use in the treatment of blood vessel disorders. Pathogenic blood vesse... |
